Primaquine to prevent transmission of falciparum malaria

The Lancet Infectious Diseases

Volumn 13, Issue 2, 2013, Pages 175-

  White, Nicholas J ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; PRIMAQUINE;

DISEASE TRANSMISSION; HEMOLYSIS; HUMAN; MALARIA CONTROL; MALARIA FALCIPARUM; NONHUMAN; NOTE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; SINGLE DRUG DOSE;

EID: 84872595849     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70198-6     Document Type: Note

References (72)

1. Guidelines for the treatment of malaria 2010, WHO, World Health Organization, Geneva.
2. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009, 361:455-467.
3. Phyo AP, Nkhoma S, Stepniewska K, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 2012, 379:1960-1966.
4. The treatment of malaria: 4th general report of the Malaria Commission 1937, League of Nations, League of Nations, Geneva.
5. Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996, 347:1654-1658.
6. Hallett RL, Sutherland CJ, Alexander N, et al. Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob Agents Chemother 2004, 48:3940-3943.
7. Drakeley CJ, Jawara M, Targett GA, et al. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop Med Int Health 2004, 9:53-61.
8. Barnes KI, White NJ Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop 2005, 94:230-240.
9. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J 2008, 7:e125.
10. Shekalaghe S, Drakeley C, Gosling R, et al. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One 2007, 2:e1023.
11. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother 2004, 48:1329-1334.
12. Adjalley SH, Johnston GL, Li T, et al. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc Natl Acad Sci USA 2011, 108:E1214-E1223.
13. Mühlens P Die Behandlung der natuerlichen menschlichen Malaria-Infektionen mit Plasmochin. Arch F Schiffs u Tropen Hyg 1926, 30:25-32.
14. Schulemann W, Memmi G Plasmochin, ein synthetisches gegen, die Malariainfektion wirksames Chinolinderivat. Arch F Schiffs u Tropen Hyg 1927, 31:59-88.
15. Wiselogle FY A survey of antimalarial drugs 1941-1945 1946, J Edwards, Ann Arbor, MI.
16. Brondz I, Mantzilas D, Klein U, et al. Nature of the main contaminant in the anti malaria drug primaquine diphosphate: a qualitative isomer analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 800:211-223.
17. Bruce-Chwatt LJ Malaria research and eradication in the USSR. A review of Soviet achievements in the field of malariology. Bull World Health Organ 1959, 21:737-772.
18. Bousema T, Okell L, Shekalaghe S, et al. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J 2010, 9:e136.
19. Bousema T, Drakeley C Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev 2011, 24:377-410.
20. Smithuis F, Kyaw MK, Phe O, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis 2010, 10:673-681.
21. Barber MA, Komp WHW The viability of gametocytes in the blood of plasmochin-treated patients: 16th annual report of the Medical Department 1927, 60-62. United Fruit Co, New York, NY.
22. Barber MA, Komp WH, Newman BM The effect of small doses of plasmochin on the viability of gametocytes of malaria as measured by mosquito infection experiments: public health report 1929, 1409-1420. United Fruit Co, New York, NY.
23. Manson-Bahr PH The action of plasmochin on malaria. Proc R Soc Med 1927, 20:919-926.
24. Green R The treatment of crescent carriers with " plasmoquine compound" Bull Inst Med Res Fed Malay States 1929, 3:4-21.
25. Amies CR Use of plasmoquine in subtertian malaria. Bull Inst Med Res Fed Malay States 1930, 5:1-37.
26. Jerace F, Giovannola A L'azzione sterlizzante della plasmochina sui gametociti di parassiti malarigeni e sua importanza profilattica. Riv Malariol 1933, 12:457-477.
27. Chopra RN, Basu BC A preliminary report of the effect of anti malarial drugs on the infectivity of the patients to the mosquitoes. Indian J Med Res 1937, 25:459-464.
28. Dick GW, Bowles RV The value of plasmoquine as a gametocide in sub-tertian malaria. Trans R Soc Trop Med Hyg 1947, 40:447-450.
29. MacKerras MJ, Ercole QN Observations on the action of quinine, atebrin and plasmoquine on the gametocytes of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1949, 42:455-463.
30. Rieckmann KH, McNamara JV, Frischer H, Stockert TA, Carson PE, Powell RD Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. Bull World Health Organ 1968, 38:625-632.
31. Rieckmann KH, McNamara JV, Kass L, Powell RD Gametocytocidal and sporontocidal effects of primaquine upon two strains of Plasmodium falciparum. Mil Med 1969, 134:802-819.
32. Jeffrey GM, Young MD, Eyles DE The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine- and pyrimethamine-treated cases. Am J Hyg 1956, 64:1-11.
33. Young MD The effect of small doses of primaquine upon malaria infections. Indian J Malariol 1959, 13:69-74.
34. Burgess RW, Bray RS The effect of a single dose of primaquine on the gametocytes, gametogony and sporogony of Laverania falciparum. Bull World Health Organ 1961, 24:451-456.
35. Gunders AE The effect of a single dose of pyrimethamine and primaquine in combination upon gametocytes and sporogony of Laverania falciparum; Plasmodium falciparum in Liberia. Bull World Health Organ 1961, 24:650-653.
36. Jeffrey GM, Collins WE, Skinner JC Antimalarial drug trials on a multiresistant strain of Plasmodium falciparum. Am J Trop Med Hyg 1963, 12:844-850.
37. Clyde DF, Dupont HL, Miller RM, McCarthy VC Prophylactic and sporontocidal treatment of chloroquine resistant Plasmodium falciparum from Malaya. Trans R Soc Trop Med Hyg 1970, 64:834-838.
38. Clyde DF, Miller RM, Music SI, McCarthy VC Prophylactic and sporontocidal treatment of chloroquine-resistant Plasmodium falciparum from Vietnam. Am J Trop Med Hyg 1971, 20:1-5.
39. Chen PQ, Li GQ, Guo XB, et al. The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chin Med J (Engl) 1994, 107:709-711.
40. Chomcharn Y, Surathin K, Bunnag D, Sucharit S, Harinasuta T Effect of a single dose of primaquine on a Thai strain of Plasmodium falciparum. Southeast Asian J Trop Med Public Health 1980, 11:408-412.
41. Lederman ER, Maguire JD, Sumawinata IW, et al. Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in central Java, Indonesia. Malar J 2006, 5:e108.
42. El-Sayed B, El-Zaki SE, Babiker H, et al. A randomized open-label trial of artesunate-sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan. PLoS One 2007, 2:e1311.
43. Bunnag D, Harinasuta T, Pinichpongse S, Suntharasamai P Effect of primaquine on gametocytes of Plasmodium falciparum in Thailand. Lancet 1980, 316:91.
44. Ponnudurai T, Lensen AH, Van Gemert GJ, Bensink MP, Bolmer M, Meuwissen JH Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Parasitology 1989, 98:165-173.
45. Chotivanich K, Sattabongkot J, Udomsangpetch R, et al. Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob Agents Chemother 2006, 50:1927-1930.
46. Beutler E G6PD deficiency. Blood 1994, 84:3613-3636.
47. Cappellini MD, Fiorelli G Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008, 371:64-74.
48. Dern RJ, Beutler E, Alving AS The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity. J Lab Clin Med 1955, 45:30-39.
49. Abeyaratne KP, Halpe NL Sensitivity to primaquine in Ceylonese children due to deficiency of erythrocytic glucose-6-phosphate dehydrogenase. Ceylon Med J 1968, 13:134-138.
50. Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration: a preliminary report. Bull World Health Organ 1960, 22:621-631.
51. Brewer GJ, Zarafonetis CJ The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism. Bull World Health Organ 1967, 36:303-308.
52. Clyde DF Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull World Health Organ 1981, 59:391-395.
53. Thimasarn K Current measures of containment of multi-drug resistant falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health 1992, 23(suppl 4):139-142.
54. Clyde DF Mass administration of an antimalarial drug combining 4-aminoquinoline and 8-aminoquinoline in Tanganyika. Bull World Health Organ 1962, 27:203-212.
55. Yip K Antimalarial work in China: a historical perspective. Parassitologia 1998, 40:29-38.
56. Kondrashin AV, Baranova AM, Sergiev VP Widespread use of primaquine for control of Plasmodium vivax epidemics in a population with varying degrees of G6PD deficiency. Med Parazitol (Mosk) 2010, 4:4-8.
57. Baird JK, Surjadjaja C Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol 2011, 27:11-16.
58. Shekalaghe SA, ter Braak R, Daou M, et al. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother 2010, 54:1762-1768.
59. Vásquez AM, Sanín F, Alvarez LG, Tobón A, Ríos A, Blair S Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects of gametocytic development. Biomedica 2009, 29:307-319. (Spanish).
60. Giao PT, de Vries PJ, Binh TQ, Nam NV, Kager PA CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine compared with atovaquone-proguanil against faciparum malaria in Vietnam. Trop Med Int Health 2004, 9:209-216. Hung IeQ.
61. Kamtekar KD, Gogtay NJ, Dalvi SS, et al. A prospective sutdy evaluating the efficacy of a single, 45 mg dose of primaquine, as a gametocytocidal agent, in patients with Plasmodium falciparum malaria in Mumbai, India. Ann Trop Med Parasitol 2004, 98:453-458.
62. Suputtamongkol Y, Chindarat S, Silpasakorn S, et al. The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia. Am J Trop Med Hyg 2003, 68:620-623.
63. Kyaw M-P, Oo M, Naing A, Htwe A-L The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar. Southeast Asian J Trop Med Public Health 1994, 25:113-170.
64. Beutler E, Duparc S Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg 2007, 77:779-789. G6PD Deficiency Working Group.
65. Luzzatto L The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics. Lancet 2010, 376:739-741.
66. Updated WHO policy recommendation (October 2012): single dose primaquine as a gametocytocide in Plasmodium falciparum malaria WHO, (accessed Nov 7, 2012). http://www.who.int/malaria/pq_updated_policy_recommendation_en_102012.pdf.
67. Global plan for artemisinin resistance containment (GPARC) WHO, (accessed Aug 14, 2012). http://www.who.int/malaria/publications/atoz/artemisinin_resistance_containment_2011.pdf.
68. Myint HY, Berman J, Walker L, et al. Review: improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations. Am J Trop Med Hyg 2011, 85:1010-1014.
69. Edwards G, McGrath CS, Ward SA, et al. Interactions among primaquine, malaria infection and other antimalarials in Thai subjects. Br J Clin Pharmacol 1993, 35:193-198.
70. Al-Sweedan SA, Jdaitawi H, Khriesat WM, Khader YY, Al-Rimawi HS Predictors of severe hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency following exposure to oxidant stresses. Hematol Oncol Stem Cell Ther 2009, 2:354-357.
71. Song J, Socheat D, Tan B, et al. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine. Malar J 2010, 9:e57.
72. Schmidt LH, Alexander S, Allen L, Rasco J Comparison of the curative antimalarial activities and toxicities of primaquine and its d and l isomers. Antimicrob Agents Chemother 1977, 12:51-60.